Rallybio Corp (RLYB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $88.03M
Last updated: Nov 17, 2026 at 4:15 PM ET
Rallybio Corp (RLYB) Stock Chart
Rallybio (RLYB) has a latest price of $15.29 on Nov 17, 2026, 13.0% below its 52-week high of $17.57. Its price rose 453.1% over the past 12 months. The month-end price fell 89.1% over the 5 years through Oct 2026, a compound annual decline of 35.8%.
Price Chart
From Jul 2021 to Oct 2026, its highest month-end close was $142.80 in Oct 2021 and its lowest $2.47 in May 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart RLYB with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for RLYB.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 66.6%, and over 6 months it rose 99.6%. The month-end price fell 53.8% over the 3 years through Oct 2026, a compound annual decline of 22.7%.
| Period | Change |
|---|---|
| 1 month | +73.3% |
| 3 months | +66.6% |
| 6 months | +99.6% |
| 12 months | +453.1% |
| 12 months, with dividends | +943.7% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -53.8% | -22.7% |
| 5 years | -89.1% | -35.8% |
Price by Year
Its best calendar year was 2025, when the price fell 28.5%, and its weakest was 2023, when it fell 63.6%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $15.54 | +183.1% |
| 2025 | $5.49 | -28.5% |
| 2024 | $7.68 | -59.8% |
| 2023 | $19.12 | -63.6% |
| 2022 | $52.56 | -31.1% |
Trading Range
The price is 48.0% above its 50-day average of $10.33 and 99.2% above its 200-day average of $7.68.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $15.29 | |
| 52-week high | $17.57 | -13.0% |
| 52-week low | $3.67 | +316.6% |
| 50-day average | $10.33 | +48.0% |
| 200-day average | $7.68 | +99.2% |
Price Risk
Over 3 years, its largest fall from a peak was 92.3%.
| Measure | Value |
|---|---|
| 1-year beta | 1.07 |
| Largest fall, 1 year | -31.0% |
| Largest fall, 3 years | -92.3% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About RLYB
What is RLYB's 1-year price change?
Rallybio's price rose 453.1% over the past 12 months. With dividends included, the 12-month total return was 943.7%.
What is RLYB's 5-year price change?
Rallybio's month-end price fell 89.1% over the 5 years through Oct 2026, a compound annual decline of 35.8%. These figures leave out dividends.
What is RLYB's 52-week high and low?
Rallybio's 52-week high is $17.57 and its 52-week low is $3.67. Its latest price of $15.29 on Nov 17, 2026 is 13.0% below the high.
What is RLYB's beta?
Rallybio's 1-year beta against the S&P 500 is 1.07, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 31.0%.
Is the RLYB chart free?
Yes. Advanced Charting for RLYB is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
RLYB pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors